Home › Companies › ASENSUS SURGICAL INC. › 2024-2025
At ASENSUS SURGICAL INC.'s shareholder meeting held August 20, 2024, in the 2024-2025 proxy season, 54 asset managers reported how they voted in their SEC Form N-PX filings, covering 82 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, in a non-binding advisory vote, certain compensation that may be paid or become… — FOR was 78% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ASENSUS SURGICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on August 20, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ASENSUS SURGICAL INC.’s Form 8-K, filed August 20, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of August 20, 2024: 2 items on ASENSUS SURGICAL INC.’s Form 8-K, filed August 20, 2024: 1 approved · 1 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025
Explore ASENSUS SURGICAL INC. in the interactive database Compare manager voting policies
These tallies are ASENSUS SURGICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 20, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Merger Agreement Proposal | 137,258,840 | 23,156,038 | 1,051,130 | -- | -- | 86% | Approved | — |
| 2. Merger-Related Compensation Proposal | 123,817,981 | 34,078,887 | 3,569,139 | -- | -- | 78% | Not verified | — |
Source: ASENSUS SURGICAL INC., Form 8-K, filed with the SEC on August 20, 2024 — read the filing on EDGAR.
Each item below shows how the 54 asset managers that disclosed a ASENSUS SURGICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ASENSUS SURGICAL INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
86% Approved · of votes cast
Description as filed by funds: To approve and adopt the Agreement and Plan of Merger, dated as of June 6, 2024 (the "Merger Agreement"), by and among KARL STORZ Endoscopy-America, Inc., a California corporation ("Parent"), and Karl Storz California Inc., a California corporation ("Merger Sub"), pursuant to which Asensus Surgical, Inc. would be acquired by way of a merger with and into Merger Sub with Asensus Surgical, Inc. surviving the merger.
ASENSUS SURGICAL INC.’s own tally for this item (“1. Merger Agreement Proposal”): 137,258,840 for, 23,156,038 against — passed, per its Form 8-K filed August 20, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders voted to approve the proposal to approve and adopt the Agreement and Plan of Merger, dated as of June 6, 2024, by and among the Company, KARL STORZ Endoscopy-America, Inc., a California corporation (“Parent”), and Karl Storz California Inc., a California corporation (“Merger Sub”),…”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 4 asset managers below reported 12,144,551 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,502,808 | 0 | 0 | 0 | For |
| Fidelity | 551,624 | 0 | 0 | 0 | For |
| Charles Schwab | 88,725 | 0 | 0 | 0 | For |
| Guggenheim | 1,394 | 0 | 0 | 0 | For |
100% of fund votes cast · no official result
Description as filed by funds: To approve one or more adjournments of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the merger proposal at the time of the special meeting.
The 4 asset managers below reported 12,144,551 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,502,808 | 0 | 0 | 0 | For |
| Fidelity | 551,624 | 0 | 0 | 0 | For |
| Charles Schwab | 88,725 | 0 | 0 | 0 | For |
| Guggenheim | 1,394 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: To approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger.
ASENSUS SURGICAL INC.’s own tally for this item (“2. Merger-Related Compensation Proposal”): 123,817,981 for, 34,078,887 against, per its Form 8-K filed August 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,502,808 | 0 | 0 | 0 | For |
| Fidelity | 551,624 | 0 | 0 | 0 | For |
| Charles Schwab | 88,725 | 0 | 0 | 0 | For |
| Guggenheim | 1,394 | 0 | 0 | 0 | For |
Fund voting reports, all 4 managers: 12,144,551 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ODDO BHF ASSET MANAGEMENT SAS | 13,550,000 | 0 | 0 | 0 | For |
| BlackRock | 1,891,796 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 568,853 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 290,329 | 0 | 0 | Against |
| State Street | 117,772 | 0 | 0 | 0 | For |
| Mirador Capital Partners LP | 0 | 0 | 110,000 | 0 | Abstain |
| Charles Schwab | 88,725 | 0 | 0 | 0 | For |
| Vanguard | 85,474 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 24,194 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 20,221 | 0 | 0 | 0 | For |
| FIRST MERCHANTS CORP | 14,000 | 0 | 0 | 0 | For |
| Clear Harbor Asset Management, LLC | 10,000 | 0 | 0 | 0 | For |
| Dimensional | 0 | 5,401 | 0 | 0 | Against |
| First Affirmative Financial Network | 3,831 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 3,336 | 0 | 0 | 0 | For |
| CIBC Private Wealth Group LLC | 3,300 | 0 | 0 | 0 | For |
| First Trust | 2,000 | 0 | 0 | 0 | For |
| TRUIST FINANCIAL CORP | 1,678 | 0 | 0 | 0 | For |
| Guggenheim | 1,394 | 0 | 0 | 0 | For |
| HighTower Advisors, LLC | 1,229 | 0 | 0 | 0 | For |
| RBC Dominion Securities Inc. | 1,177 | 0 | 0 | 0 | For |
| COMERICA BANK | 1,077 | 0 | 0 | 0 | For |
| RWA WEALTH PARTNERS, LLC | 1,000 | 0 | 0 | 0 | For |
| STEPHENS INC /AR/ | 770 | 0 | 0 | 0 | For |
| Prudential/PGIM | 700 | 0 | 0 | 0 | For |
Institutional-manager reports, all 50 managers: 16,396,050 for, 295,807 against, 110,000 abstained. Showing the 25 largest; every one is in the interactive database (link above).
100% of fund votes cast · no official result
The 2 asset managers below reported 9,000 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TD ASSET MANAGEMENT INC | 5,000 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 4,000 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 272,842,574 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.22% |
| 2 | Fidelity | 0.20% |
| 3 | Charles Schwab | 0.03% |
| 4 | Guggenheim | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ODDO BHF ASSET MANAGEMENT SAS | 4.97% |
| 2 | BlackRock | 0.69% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.21% |
| 4 | Northern Trust | 0.11% |
| 5 | State Street | 0.04% |
| 6 | Mirador Capital Partners LP | 0.04% |
| 7 | Charles Schwab | 0.03% |
| 8 | Vanguard | 0.03% |
| 9 | MELLON INVESTMENTS Corp | <0.01% |
| 10 | Fisher Asset Management, LLC | <0.01% |
Percentages above are of 272,842,574 shares outstanding, as reported by ASENSUS SURGICAL INC. on its Form 10-Q dated August 6, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ASENSUS SURGICAL INC.’s 10-Q dated August 6, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
ASENSUS SURGICAL INC. proxy season coverage: 2024-2025 (this page).
proxyvotesnow.com, “ASENSUS SURGICAL INC. 2024 Special Meeting (2024-2025 season)”, https://proxyvotesnow.com/company/asensus-surgical-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.